ASTM F2065-00e1
Historical Standard: ASTM F2065-00e1 Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials
SUPERSEDED (see Active link, below)
ASTM F2065
1. Scope
1.1 This practice provides a protocol for rapid, in vitro screening for alternative pathway complement activating properties of solid materials used in the fabrication of medical devices that will contact blood.
1.2 This practice is intended to evaluate the acute in vitro alternative pathway complement activating properties of solid materials intended for use in contact with blood. For this practice, 'serum' is synonymous with 'complement.'
1.3 This practice consists of two procedural parts. Procedure A describes exposure of solid materials to a standard lot of C4-deficient guinea pig serum [C4(-)GPS], using 0.1-mL serum per 13 100-mm disposable glass test tubes. Sepharose is used as an example of test materials. Procedure B describes assaying the exposed serum for significant functional alternative pathway complement depletion as compared to control samples. The endpoint in procedure B is lysis of rabbit RBC in buffer containing EGTA and excess Mg ++ .
1.4 This practice does not address function, elaboration, or depletion of individual complement components except as optional additional confirmatory information that can be acquired using human serum as the complement source. This practice does not address the use of plasma as a source of complement.
1.5 This practice is one of several developed for the assessment of the biocompatibility of materials. Practice F748 may provide guidance for the selection of appropriate methods for testing materials for other aspects of biocompatibility. Practice F1984 provides guidance for testing solid materials for whole complement activation in human serum, but does not discriminate between the classical or alternative pathway of activation.
2. Referenced Documents (purchase separately) The documents listed below are referenced within the subject standard but are not provided as part of the standard.
ASTM Standards
F748 Practice for Selecting Generic Biological Test Methods for Materials and Devices
F1984 Practice for Testing for Whole Complement Activation in Serum by Solid Materials
Other Document
ISO10993-4: Biological Evaluation of Medical Devices. Part 4: Selection of Tests for Interactions with Blood Available from American National Standards Institute (ANSI), 25 W. 43rd St., 4th Floor, New York, NY 10036.Keywords
alternative pathway; biocompatibility; blood compatibility; complement testing; materials; medical devices; Alternative pathway complement activation; Barbitol (veronal) buffer; Biocompatibility; Blood compatibility; Blood materials/applications; C-4 deficient Guidea Pig serum (C4-GPS); Complement activation; Fabrication (of medical devices); Medical devices/equipment; Rabbit RBC (red blood cells); Red blood cells (RBC); Screen analysis--medical/surgical applications; Serum; Sheep RBC (red blood cells); Solid phase materials; in vitro Evaluation;
ICS Code
ICS Number Code 11.040.40 (Implants for surgery, prothetics and orthotics)
DOI: 10.1520/F2065-00E01
ASTM International is a member of CrossRef.